Abstract:The interaction between Nitisinone (NTBC) and bovine serum albumin (BSA) as the transport protein in a circulating system was investigated for the first time utilizing various analytical (UV–Vis spectrophotometry, fluorescence spectroscopy, dynamic light scattering, and differential scanning calorimetry) and computational (molecular docking and molecular dynamics simulations) methods. The BSA fluorescence intensity was quenched upon interaction with NTBC, and the quenching mechanism was observed as static. The interaction between NTBC and BSA was examined at 288 K, 298 K, and 308 K where the binding constants were found to be 1.44 × 10 5 ± 0.22 M −1 , 5.18 × 10 4 ± 0.20 M −1 , and 3.02 × 10 4 ± 0.22 M −1 respectively, suggesting an intermediate binding affinity between NTBC and BSA. Changes in the microenvironment surrounding tryptophan and tyrosine residues of BSA were elucidated using 3-D fluorescence spectroscopy. Thermodynamic studies revealed the calculated values of ΔH = − 54.34 ± 5 kJ/mol and ΔS = − 0.0908 ± 0.24 kJ/mol K −1 , indicating the involvement of van der Waals forces and hydrogen bonds in the interaction between NTBC and BSA. Moreover, the interaction's spontaneous nature was evidenced by negative ΔG values across all temperatures. Using dynamic light scattering, it was observed that higher NTBC concentrations led to a gradual rise in hydrodynamic diameter and notable aggregation of the NTBC-BSA complex. Moreover, changing signal values and shifted peaks of BSA, NTBC, and complex in differential scanning calorimetry curves, meant there were molecular interactions between the NTBC and BSA. In silico approaches also elucidated how NTBC binds to active sites on BSA, further supporting other findings. Moreover, molecular docking studies offer a more profound insight into the changing dynamics of hydrophobic, hydrogen, and halogen bonding involved in stabilizing the NTBC-BSA complex.

Exploring the binding characteristics of bovine serum albumin with tyrosine Kinase inhibitor Entrectinib: Multi-spectral Analysis and theoretical calculation

Spectroscopic and Molecular Docking Studies of Binding Interaction of Gefitinib, Lapatinib and Sunitinib with Bovine Serum Albumin (BSA).

Combined Spectroscopies and Molecular Docking Approach to Characterizing the Binding Interaction of Enalapril with Bovine Serum Albumin.

Binding Interaction of Sorafenib with Bovine Serum Albumin: Spectroscopic Methodologies and Molecular Docking.

Evaluation of the interaction of novel tyrosine kinase inhibitor apatinib mesylate with bovine serum albumin using spectroscopies and theoretical calculation approaches

Multi-spectral and docking assessments to explore the combination of an antiviral drug, entecavir with bovine serum albumin

A Biophysical Study of Molecular Interaction of Tucatinib with Bovine Serum Albumin

In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods.

Exploring the binding characteristics of bovine serum albumin with CDK4/6 inhibitors Ribociclib: Multi-spectral analysis and molecular simulation studies

Binding Interaction of Ramipril with Bovine Serum Albumin (BSA): Insights from Multi-Spectroscopy and Molecular Docking Methods.

Multispectroscopic, electrochemical and molecular docking approaches on binding comparison of camptothecin, 10-hydroxycamptothecin to bovine serum albumin

Exploring the interaction of a potent anti‐cancer drug Selumetinib with bovine serum albumin: Spectral and computational attributes

Probing into the binding interaction between medroxyprogesterone acetate and bovine serum albumin (BSA): spectroscopic and molecular docking methods.

Unraveling the interaction mechanism between orphan drug Nitisinone and bovine serum albumin through spectroscopic and in silico approaches

Screening and evaluation of the hit compound from a DNA-encoded library derived from natural products based on immobilized endothelin receptor A

Characterization of Interaction Between Raltitrexed and Bovine Serum Albumin by Optical Spectroscopic Techniques

Evaluation of the binding behavior of olmutinib (HM61713) with model transport protein: Insights from spectroscopic and molecular docking studies

Binding of a bcl-2 family inhibitor to bovine serum albumin: fluorescence quenching and molecular docking study.

Deciphering The Binding Behaviours Of Bsa Using Ionic Aie-Active Fluorescent Probes

Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug–Protein and Drug–Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches

Spectroscopic Study on the Interaction of Bovine Serum Albumin with Zinc(ii) Phthalocyanine.